Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  1. Simvastatin improves mitochondrial respiration in peripheral blood cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cell-Free Fetal DNA in the Early and Late First Trimester

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Tyrosylprotein Sulfotrasferases

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  4. Cell-specific precursor processing

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Posttranslational processing of progastrin

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Mutations in the butyrylcholinesterase enzyme (BChE) can result in prolonged duration of action of the neuromuscular blocking agents, succinylcholine and mivacurium, as BChE hydrolyses these drugs. Hereditary low BChE activity can cause extensively prolonged apnoea during general anaesthesia when these drugs are used. The aim of this study was to describe novel mutations in the butyrylcholinesterase gene (BCHE) in patients who have experienced prolonged duration of action of mivacurium or succinylcholine.

METHODS: The Danish Cholinesterase Research Unit registers patients with prolonged duration of action to succinylcholine and mivacurium. Patients were studied if they had equivocal phenotypes on the basis of BChE activity, biochemical inhibitor reactions and with pedigree if possible. Complete nucleotide sequencing was performed to describe the genotype and pedigree was used to separate the alleles. Multiple sequence alignment of BChE was performed for comparison with other species.

RESULTS: Genotyping indicated seven novel mutations in the BCHE (I373T, G467S, W518R, L184S, V421A, M462I and R577H).

CONCLUSION: We have found seven new variants of the BCHE, which seem to reduce the activity of BChE in patients undergoing anaesthesia involving succinylcholine or mivacurium.

Original languageEnglish
JournalPharmacogenetics and Genomics
Volume26
Issue number7
Pages (from-to)351-6
Number of pages6
ISSN1744-6872
DOIs
Publication statusPublished - Jul 2016

    Research areas

  • Journal Article

ID: 49819618